Synthesis and anabolic/androgenic evaluation of novel 9α-fluorosteroids

European Journal of Medicinal Chemistry

Volumn 44, Issue 11, 2009, Pages 4567-4571

  Reyes Moreno, M ^a   Ruiz Garcia J A ^a   Ibarra Reyes, Y ^a   Fuente Hernandez A ^a   Velez Castro H ^a   Hernandez Balmaseda I ^a   Martinez Hormaza I ^a   Rodeiro Guerra, I ^a   Ramírez, J Sandoval ^b   Reyes, S Meza ^b   Montiel Smith, S ^b  

^a Centro de Quimica Farmaceutica   (Cuba)

^b BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

Author keywords

Anabolic activity; Androgenic activity; Androstane derivates; Steroids

Indexed keywords

3BETA ACETOXY 9ALPHA FLUOR 11BETA HYDROXY 5ALPHA ANDROSTAN 17 ONE; 3BETA ACETOXY 9ALPHA FLUOR 11BETA HYDROXY 5ALPHA ANDROSTANE; 3BETA ACETOXY 9ALPHA FLUOR 11BETA HYDROXY 5ALPHA ANDROSTANE 17BETA ENANTHATE; 3BETA ACETOXY 9ALPHA FLUOR 11BETA HYDROXY 5ALPHA ANDROSTANE 17BETA ISOBUTYRATE; 3BETA ACETOXY 9ALPHA FLUOR 11BETA,17BETA DIHYDROXY 5ALPHA ANDROSTANE; 3BETA,11BETA DIHYDROXY 9ALPHA FLUOR 5ALPHA ANDROSTANE 17 ONE; 3BETA,17BETA DIAACETOXY 9ALPHA FLUOR 11BETA HYDROXY 5ALPHA ANDROSTANE; FLUORINATED STEROID; TESTOSTERONE; TESTOSTERONE PROPIONATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; MALE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RAT;

ANABOLIC AGENTS; ANDROGENS; ANDROSTANES; ANIMALS; FLUORINE; MALE; MUSCLES; ORGAN SIZE; PROSTATE; RATS; RATS, WISTAR; SEMINAL VESICLES;

EID: 70349759377     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2009.06.025     Document Type: Article

References (19)

1. W. Llewellyn, Anabolics 2004. 22-308 Júpiter, FL 33458, 2004, pp. 3-10.
2. Bowers M. Anabolic steroids in the treatment of HIV-related wasting. Bull. Exp. Treat. AIDS No. 30 (1996) Sept
3. Morales P.M.R.S., and Valle E. Treatment results of 23 cases of severe aplastic anemia with lymphocytapheresis. Arch. Med. Res. 28 (Spring 1997) 85-90
4. Dunn J.M. HIV Hotline 8 (1998) 4-5
5. Phillips W.N. Anabolic Reference Guide (1991)
6. Murad R.F., and Haynes Jr. C. Androgen and Anabolic Steroids. In: Goodman L.S., and Gilman A. (Eds). Revolucionaria. The Pharmacological Base of the Therapeutic vol. III (1984) 1413-1429
7. Anabolic Steroids, www.saludhoy.com/html/depor/articulo/esteroid.html.
8. Hudlicky M., and Pavlath A.E. Biological Properties of Fluorinated Compounds. Chemistry of Organic Fluorine Compounds II: A Critical Review. ACS Monograph 187 (1995), American Chemical Society, Washington, DC
9. O'Hagan D., and Rzepa H.S. Some influences of fluorine in bioorganic chemistry. Chem. Commun. 7 (1997) 645-652
10. L. Herr, Preparation of fluoxymesterone, U.S. Pat., 2, 813, 881, 1957 to Upjohn.
11. Brueggemeier R.W. Male Sex Hormones, Analogs, and Antagonists. In: Abraham D. (Ed). Burger's Medicinal Chemistry & Drug Discovery. sixth ed. vol. 3 (2003), John Wiley & Sons, New York 679-746
12. Vida J.A. Androgens and Anabolic Agents vol. 5 (1969), Academic Press, New York and London pp. 2544-2550
13. J.A. Ruiz, Tesis en Opción al Título de Doctor en Ciencias Farmacéuticas, 1999.
14. Reyes M., Fuente A., Ruiz J.A., Álvarez Y.M., Vélez H., Fernández A., Montiel S., Meza S., and Sandoval J. Oxidation reactions in 9α-halosteroids by Jones reagent. J. Mex. Chem. Soc. 51 4 (2007) 232-236
15. 13C NMR spectral assignment of androstane derivatives. Magn. Reson. Chem. 43 (2005) 676-678
16. 13C NMR spectra of steroids. A survey and commentary. Org. Magn. Reson. 9 8 (1977) 439-463
17. E. Pretsch, T. Clerc, J. Seibl, W. Simon, Tablas para la elucidación estructural de compuestos orgánicos por métodos espectroscópicos. Versión española de J. Castells y F. Camps. Ed. Alhambra Longman, 1995.
18. Friedel A., Geyer H., Kamber M., Laudenbach-Leschowsky U., Schanzer W., and Thevis M. 17β-Hydroxy-5α-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties. Toxicol. Lett. 165 (2006) 149-155
19. Yamasaki K., Sawaki M., Ohta R., Okuda H., Katayama S., Yamada T., Ohta T., Kosaka T., and Owens W. OECD validation of the Hershberger assay in Japan: phase 2 dose response of methyltestosterone, vinclozolin, and p,p′-DDE. Environ. Health Perspect. 111 16 (2003) 1912-1919